QIFENG
873169
LEETRO
430425
KSEC Intelligent Technology
301311
4
Guangdong Topstar Technology
300607
5
Hengerda New Materials
300946
CN Stock MarketDetailed Quotes
688065 Cathay Biotech Inc.
- 50.66
- -0.45-0.88%
Market Closed May 12 15:00 CST
36.54BMarket Cap70.17P/E (TTM)
51.54High50.38Low29.00KlotVolume51.54Open51.11Pre Close147.09MTurnover0.50%Turnover Ratio74.72P/E (Static)721.29MShares56.9852wk High2.08P/B29.55BFloat Cap32.4852wk Low61.33Limit Up583.38MShs Float140.21Historical High40.89Limit Down2.27%Amplitude32.48Historical Low0.19Dividend TTM50.73Avg Price15.81KlotAsk0.38%Div YieldTTM100Lot Size11.34KlotBid
Cathay Biotech Inc. News
Cathay Biotech: Announcement on holding the 2024 and 2025 First Quarter Results Briefing
Kaisai Biotech: Announcement on holding the 2025 Shanghai Listed Company Annual Report Group Performance Briefing
Kaisai Biotech: 2025 First Extraordinary General Meeting of Shareholders Meeting Information
2025 First Extraordinary General Meeting of Shareholders Meeting Materials
Announcement on holding the 2024 and 2025 first quarter results briefing
Announcement on holding the 2025 Shanghai Listed Company Annual Report Group Performance Briefing
Cathay Biotech: Announcement on the progress of repurchasing the company\'s shares through centralized bidding transactions
Announcement on the progress of repurchasing the company\'s shares through centralized bidding transactions
Kaiser Biotech: First Quarter 2025 Report
2025 First Quarter Report
Kaisai Biotech: Audit Report issued by Tianjian Certified Public Accountants (Special General Partnership) on the Company\'s 2024 Annual Report
Kaisai Biotech: 2024 Independent Director Debriefing Report (Wu Xiangyang)
Cathay Biotech: China Merchants Securities Co., Ltd.\'s inspection opinions on the storage and use of funds raised by Shanghai Kaisai Biotechnology Co., Ltd. in 2024
Cathay Biotech: Non-operating capital occupation and other related capital transactions in 2024
Kaiser Biotech: 2024 Annual Report Summary
Cathay Biotech: 2024 Board Audit Committee Performance Report
Kaisai Biotech: Report on the Audit Committee\'s performance of supervisory duties on accounting firms
Kaisai Biotech: 2025 Action Plan to Improve Quality, Increase Efficiency, and Reward
Kaisai Biotech: 2024 Independent Director Debriefing Report (Lu Faqin)
Kaisai Biotech: Tianjian Certified Public Accountants (Special General Partnership) Audit Report on the Company\'s Internal Control